Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Cleton-Jansen

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Nature Genetics|February 1, 1994
Instability of short tandem repeats (microsatellites) in human cancersR Wooster, A M Cleton-Jansen, N Collins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistanceJ G van Oosterwijk, B Herpers, D Meijer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomasJ K Anninga, M J van de Vijver, A M Cleton-Jansen, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2T Peelen, R S Cornelis, M van Vliet, et al.
British Journal of Cancer|November 6, 2009
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathwaysA-M Cleton-Jansen, J K Anninga, I H Briaire-de Bruijn, et al.
British Journal of Cancer|December 10, 2009
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathwaysA-M Cleton-Jansen, J K Anninga, I H Briaire-de Bruijn, et al.
The Journal of Pathology|March 13, 1998
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situW J De Leeuw, G Berx, C B Vos, et al.
British Journal of Cancer|January 1, 1997
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesisC B Vos, A M Cleton-Jansen, G Berx, et al.
Cancer Research|August 1, 1994
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutationsR S Cornelis, M van Vliet, C B Vos, et al.
British Journal of Cancer|March 31, 1999
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3A M Cleton-Jansen, E W Moerland, J C Pronk, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Nature Genetics|February 1, 1994
Instability of short tandem repeats (microsatellites) in human cancersR Wooster, A M Cleton-Jansen, N Collins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistanceJ G van Oosterwijk, B Herpers, D Meijer, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2004
Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomasJ K Anninga, M J van de Vijver, A M Cleton-Jansen, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2T Peelen, R S Cornelis, M van Vliet, et al.
British Journal of Cancer|November 6, 2009
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathwaysA-M Cleton-Jansen, J K Anninga, I H Briaire-de Bruijn, et al.
British Journal of Cancer|December 10, 2009
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathwaysA-M Cleton-Jansen, J K Anninga, I H Briaire-de Bruijn, et al.
The Journal of Pathology|March 13, 1998
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situW J De Leeuw, G Berx, C B Vos, et al.
British Journal of Cancer|January 1, 1997
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesisC B Vos, A M Cleton-Jansen, G Berx, et al.
Cancer Research|August 1, 1994
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutationsR S Cornelis, M van Vliet, C B Vos, et al.
British Journal of Cancer|March 31, 1999
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3A M Cleton-Jansen, E W Moerland, J C Pronk, et al.
Pageof 7